# Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway

> **NCT07417371** · NA · NOT_YET_RECRUITING · sponsor: **Dongdong Qin** · enrollment: 60 (estimated)

## Conditions studied

- Tourette Syndrome in Children

## Interventions

- **DRUG:** Tourette Syndrome (TS) children were administered Pei Tu Ning Feng Tang treatment.

## Key facts

- **NCT ID:** NCT07417371
- **Lead sponsor:** Dongdong Qin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07417371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07417371, "Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07417371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*